Use of Gonadotrophin Releasing Hormone (GnRH) Antagonist (Cetrotide) during Ovarian Stimulation for in-vitro Fertilization Treatment: Multiple Doses and Single Dose-Reference-Cited by-同舟云学术

Use of Gonadotrophin Releasing Hormone (GnRH) Antagonist (Cetrotide) during Ovarian Stimulation for in-vitro Fertilization Treatment: Multiple Doses and Single Dose

Published:2001-10 Issue:5 Volume:27 Page:261-265
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:

Author:

Ng Ernest Hung Yu,Ho Pak Chung

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1447-0756.2001.tb01267.x/fullpdf

Reference12 articles.

1. The routine use of gonadotropin releasing hormone agonists prior to in-vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials;Hughes;Fertil Steril,1992

2. 2. SchallyAV, Comaru-SchallyAM. Analogs of LHRH: The present and the future. In: VickeryBH, LunenfeldB., eds. GnRH Analogues in Cancer and Human Reproduction, Basic Aspects. Dordrecht, Boston London: Kluwer Academics Publ., Vol 1: 1989, 5-31.

3. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation;Diedrich;Hum Reprod,1994

4. Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: A pilot study;Olivennes;Hum Reprod,1995

5. Comparison of different doses of gonadotrophin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation;Albano;Fertil Steril,1997

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology;Reproductive Biology and Endocrinology;2014

2. Endocrinological insights into differentin vitrofertilization treatment aspects;Expert Review of Endocrinology & Metabolism;2012-07

3. Comparisons of Different Dosages of Gonadotropin-Releasing Hormone (GnRH) Antagonist, Short-acting Form and Single, Half-dose, Long-acting Form of GnRH Agonist During Controlled Ovarian Hyperstimulation and in vitro Fertilization;Taiwanese Journal of Obstetrics and Gynecology;2008-03

4. New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists;Expert Opinion on Investigational Drugs;2005-08-22

5. Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration;Fertility and Sterility;2005-06